1. Medtech Insight

Medtronic CEO Regrets Not Moving More Aggressively On Some M&A Deals During Pandemic

Geoff Martha says the COVID-19 pandemic didn’t create the kind of liquidity crisis that would have allowed bigger companies to get bargain deals on smaller medtech firms.

Medtronic CEO Geoff Martha took the helm at the start of the 2020 coronavirus pandemic
Medtronic CEO Geoff Martha took the helm at the start of the 2020 coronavirus pandemic • Source: Medtronic (SHARI FLEMING)

One of Medtronic plc CEO Geoff Martha’s regrets from this past year is not moving hard enough on some mergers and acquisitions. He also says that while the company is interested in acquiring artificial intelligence (AI) technology, it is being conservative about how it defines AI.

Martha recently spoke with Medtech Insight about his experience stepping into his new leadership role at the start of the coronavirus pandemic and helming the ship through the crisis

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business

More from Medtech Insight

Faster Device Certification Among Keys To Unlocking Innovation In EU MedTech Sector

 
• By Amanda Maxwell

While MedTech Europe sharpens its focus on what the EU most urgently needs to advance the medtech market in four targeted measures, the European Commission has also unveiled four priorities for 2025.

GE HealthCare Warns Of $500M Tariff Hit In 2025, Eyes Recovery in 2026

 
• By Shubham Singh

GE HealthCare anticipates most of the $0.85 EPS tariff impact will play out in the second half of 2025. Jay Saccaro, vice president and CFO, said the tariff-related burden is minimal in Q1 at about $10 million, rising to nearly $100 million in Q2 and then spiking to around $200 million each in Q3 and Q4.

Peerbridge Bets On At-Home Heart Monitoring With Rechargeable, Longer-Lasting ECG Patch

 
• By Marion Webb

Peerbridge Health is preparing to submit its next-generation ECG patch, CorMDx, for US FDA clearance this quarter, with plans to launch in the second half of 2025. The rechargeable device is designed for continuous, real-time heart monitoring from the hospital to home, aiming to detect early signs of heart failure and reduce emergency room visits.